Insulin pump therapy in children with type 1 diabetes: analysis of data from the SWEET registry

Intensified insulin delivery using multiple daily injections (MDI) or continuous subcutaneous insulin infusion (CSII) is recommended in children with type 1 diabetes (T1D) to achieve good metabolic control.

[1]  T. Stukel,et al.  Insulin pump use and discontinuation in children and teens: a population‐based cohort study in Ontario, Canada , 2017, Pediatric diabetes.

[2]  K. Lange,et al.  Current practice of diabetes education in children and adolescents with type 1 diabetes in Germany and Austria: analysis based on the German/Austrian DPV database , 2016, Pediatric diabetes.

[3]  R. Beck,et al.  Hemoglobin A1c (HbA1c) changes over time among adolescent and young adult participants in the T1D exchange clinic registry , 2016, Pediatric diabetes.

[4]  J. Lachin,et al.  Intensive Diabetes Treatment and Cardiovascular Outcomes in Type 1 Diabetes: The DCCT/EDIC Study 30-Year Follow-up , 2016, Diabetes Care.

[5]  J. Kleijnen,et al.  Integrated sensor-augmented pump therapy systems [the MiniMed® Paradigm™ Veo system and the Vibe™ and G4® PLATINUM CGM (continuous glucose monitoring) system] for managing blood glucose levels in type 1 diabetes: a systematic review and economic evaluation. , 2016, Health technology assessment.

[6]  K. Nørgaard,et al.  Cost‐effectiveness of continuous subcutaneous insulin infusion versus multiple daily injections of insulin in Type 1 diabetes: a systematic review , 2015, Diabetic medicine : a journal of the British Diabetic Association.

[7]  A. Rawshani,et al.  Insulin pump therapy, multiple daily injections, and cardiovascular mortality in 18 168 people with type 1 diabetes: observational study , 2015, BMJ : British Medical Journal.

[8]  B. Olsen,et al.  Insulin pump treatment; increasing prevalence, and predictors for better metabolic outcome in Danish children and adolescents with type 1 diabetes , 2015, Pediatric diabetes.

[9]  David M Maahs,et al.  Current State of Type 1 Diabetes Treatment in the U.S.: Updated Data From the T1D Exchange Clinic Registry , 2015, Diabetes Care.

[10]  G. Alexander Fleming,et al.  Insulin pump risks and benefits: a clinical appraisal of pump safety standards, adverse event reporting and research needs. A Joint Statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group , 2015, Diabetologia.

[11]  Lutz Heinemann,et al.  Insulin Pump Risks and Benefits: A Clinical Appraisal of Pump Safety Standards, Adverse Event Reporting, and Research Needs , 2015, Diabetes Care.

[12]  Reinhard W. Holl,et al.  Use of insulin pump therapy in children and adolescents with type 1 diabetes and its impact on metabolic control: comparison of results from three large, transatlantic paediatric registries , 2015, Diabetologia.

[13]  A. Berghold,et al.  Intensive glucose control versus conventional glucose control for type 1 diabetes mellitus. , 2014, The Cochrane database of systematic reviews.

[14]  N. Bratina,et al.  Improved metabolic control in pediatric patients with type 1 diabetes: a nationwide prospective 12-year time trends analysis. , 2014, Diabetes technology & therapeutics.

[15]  J. Albers,et al.  Neuropathy and Related Findings in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study , 2013, Diabetes Care.

[16]  R. Beck,et al.  Race, socioeconomic status, and treatment center are associated with insulin pump therapy in youth in the first year following diagnosis of type 1 diabetes. , 2013, Diabetes technology & therapeutics.

[17]  Stephanie R. Johnson,et al.  Long-term outcome of insulin pump therapy in children with type 1 diabetes assessed in a large population-based case–control study , 2013, Diabetologia.

[18]  B. Zinman,et al.  The Effect of Excess Weight Gain With Intensive Diabetes Mellitus Treatment on Cardiovascular Disease Risk Factors and Atherosclerosis in Type 1 Diabetes Mellitus: Results From the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study (DCCT/EDIC) Stu , 2013, Circulation.

[19]  E. Bass,et al.  Methods for Insulin Delivery and Glucose Monitoring: Comparative Effectiveness , 2012 .

[20]  B. Guerci,et al.  Access of children and adolescents with type 1 diabetes to insulin pump therapy has greatly increased in France since 2001. , 2011, Diabetes & metabolism.

[21]  J. Pickup,et al.  Insulin pumps. , 2011, International journal of clinical practice. Supplement.

[22]  V. Sulmont,et al.  Metabolic control in children with diabetes mellitus who are younger than 6 years at diagnosis: continuous subcutaneous insulin infusion as a first line treatment? , 2010, The Journal of pediatrics.

[23]  E. Renard.  Insulin pump use in Europe. , 2010, Diabetes technology & therapeutics.

[24]  Dorte Vistisen,et al.  Global healthcare expenditure on diabetes for 2010 and 2030. , 2010, Diabetes research and clinical practice.

[25]  J. Albers,et al.  Effect of Prior Intensive Insulin Treatment During the Diabetes Control and Complications Trial (DCCT) on Peripheral Neuropathy in Type 1 Diabetes During the Epidemiology of Diabetes Interventions and Complications (EDIC) Study , 2010, Diabetes Care.

[26]  Thomas Danne,et al.  Insulin treatment in children and adolescents with diabetes , 2009, Pediatric diabetes.

[27]  A J Sutton,et al.  Severe hypoglycaemia and glycaemic control in Type 1 diabetes: meta‐analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion , 2008, Diabetic medicine : a journal of the British Diabetic Association.

[28]  R. Kahn,et al.  Consensus statement on the worldwide standardisation of the HbA 1c measurement: The American Diabetes Association, European Association for the Study of Diabetes, International Federation of Clinical Chemistry and Laboratory Medicine, and the International Diabetes Federation , 2007 .

[29]  M. Phillip,et al.  Use of Insulin Pump Therapy in the Pediatric Age-Group , 2007, Diabetes Care.

[30]  Consensus Committee.  Consensus statement on the worldwide standardisation of the HbA1c measurement , 2007, Diabetologia.

[31]  Eric Charles,et al.  [Insulin pumps]. , 2005, Revue de l'infirmiere.